Obstetrics & Gynecology Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Obstetrics & Gynecology 2006;108:1283-1292
© 2006 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME Quiz
Right arrow CME Quiz Answers
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Casey, B. M.
Right arrow Articles by Leveno, K. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Casey, B. M.
Right arrow Articles by Leveno, K. J.
Related Collections
Right arrow Epidemiology/public health
Right arrow Reproductive endocrinology

CLINICAL EXPERT SERIES

Thyroid Disease in Pregnancy

Brian M. Casey, MD1 and Kenneth J. Leveno, MD1

From the 1Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas, Texas.

Thyroid testing during pregnancy should be performed on symptomatic women or those with a personal history of thyroid disease. Overt hypothyroidism complicates up to 3 of 1,000 pregnancies and is characterized by nonspecific signs or symptoms that are easily confused with complaints common to pregnancy itself. Physiologic changes in serum thyroid-stimulating hormone (TSH) and free thyroxine (T4) related to pregnancy also confound the diagnosis of hypothyroidism during pregnancy. If the TSH is abnormal, then evaluation of free T4 is recommended. The diagnosis of overt hypothyroidism is established by an elevated TSH and a low free T4. The goal of treatment with levothyroxine is to return TSH to the normal range. Overt hyperthyroidism complicates approximately 2 of 1,000 pregnancies. Clinical features of hyperthyroidism can also be confused with those typical of pregnancy. Clinical hyperthyroidism is confirmed by a low TSH and elevation in free T4 concentration. The goal of treatment with thioamide drugs is to maintain free T4 in the upper normal range using the lowest possible dosage. Postpartum thyroiditis requiring thyroxine replacement has been reported in 2% to 5% of women. Most women will return to the euthyroid state within 12 months.




This article has been cited by other articles:


Home page
 JNMHome page
E. S. Mittra, R. D. Niederkohr, C. Rodriguez, T. El-Maghraby, and I. R. McDougall
Uncommon Causes of Thyrotoxicosis
J. Nucl. Med., February 1, 2008; 49(2): 265 - 278.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
S. L. La'ulu and W. L. Roberts
Second-Trimester Reference Intervals for Thyroid Tests: The Role of Ethnicity
Clin. Chem., September 1, 2007; 53(9): 1658 - 1664.
[Abstract] [Full Text] [PDF]

Home page
 Obstet GynecolHome page
S. A. Rasmussen, M. M. Yazdy, S. L. Carmichael, D. J. Jamieson, M. A. Canfield, M. A. Honein, and for the National Birth Defects Prevention Study
Maternal Thyroid Disease as a Risk Factor for Craniosynostosis
Obstet. Gynecol., August 1, 2007; 110(2): 369 - 377.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
G. A. Brent
Diagnosing Thyroid Dysfunction in Pregnant Women: Is Case Finding Enough?
J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 39 - 41.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American College of Obstetricians and Gynecologists.